NCT03752892

Brief Summary

Idiopathic pulmonary fibrosis (IPF) is a lung disease that limits the ability to breathe enough for a good workout. One way to improve the exercise training is to reduce the number of muscles being trained together. By training one leg at a time, the patient does not have to breathe as much allowing each leg a better workout. Our groundwork suggests it may work in patients with IPF. This study will help decide whether one-legged exercise training is better at improving a patient's exercise endurance compared to the usual way of exercising with both legs at the same time.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Mar 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress99%
Mar 2019May 2026

First Submitted

Initial submission to the registry

November 20, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 26, 2018

Completed
3 months until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 28, 2025

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2026

Expected
Last Updated

December 4, 2025

Status Verified

November 1, 2025

Enrollment Period

6.2 years

First QC Date

November 20, 2018

Last Update Submit

November 27, 2025

Conditions

Keywords

pulmonary rehabilitationexercise training

Outcome Measures

Primary Outcomes (1)

  • Cycle exercise endurance time

    tolerance (time) of a constant power high intensity cycle endurance test

    Change from Baseline at discharge from 8 weeks of pulmonary rehabilitation

Secondary Outcomes (1)

  • health-related quality of life

    Change from Baseline at discharge from 8 weeks of pulmonary rehabilitation

Study Arms (2)

intervention -1-leg cycle training

EXPERIMENTAL

Primary aerobic training component one-legged, partitioned, cycle training. A progressive approach to combined intensity and duration will be taken. A cycle starting with intermittent high intensity one-legged exercise progressing to continuous duration of the target duration of 15 min for each leg and then restarting the cycle at a higher intensity.

Other: intervention -1-leg cycle training

usual care - 2-leg cycle training

ACTIVE COMPARATOR

Primary aerobic training component conventional two-legged cycle training. A progressive approach to combined intensity and duration will be taken. A cycle starting with intermittent high intensity exercise progressing to continuous duration of 30 min and then restarting the cycle at a higher intensity.

Other: usual care - 2-leg cycle training

Interventions

partitioned aerobic exercise training

intervention -1-leg cycle training

conventional aerobic exercise training

usual care - 2-leg cycle training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • confirmed idiopathic pulmonary fibrosis
  • Clinically stable
  • enrolled in pulmonary rehabilitation

You may not qualify if:

  • co-morbidities that might impair their ability to safely complete a pulmonary rehabilitation program
  • complete a pulmonary rehabilitation program within the previous 6 months
  • experienced an exacerbation less than six weeks before participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

West Park Healthcare Centre

Toronto, Ontario, M6M 2J5, Canada

Location

MeSH Terms

Conditions

Disease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Roger S Goldstein

    West Park Healthcare Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
assessor of the primary outcomes will be blind to the participant's group allocation
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: prospective, randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Program in Respiratory Rehabilitation

Study Record Dates

First Submitted

November 20, 2018

First Posted

November 26, 2018

Study Start

March 1, 2019

Primary Completion

April 28, 2025

Study Completion (Estimated)

May 31, 2026

Last Updated

December 4, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations